Photo/Zhang Jian (NBD)

NBD AI Bulletin，Bgi Genomics Co., Ltd. (the Company, SZ 300676, closing price: 196 yuan) announced its earnings forecast on the evening of July 13, and expects net profit attributable to shareholders of listed company to be 1.53 billion yuan to 1.63 billion yuan in the first half of 2020, up 672.83% to 723.35% year-on-year. The reason for performance is: 1. The Company has many years of experience in genomics and infection prevention and control, and has a wide range of products in the field of pathogen infection testing. During the reporting period, due to the global outbreak of COVID-19, the market demand for new coronavirus testing kits increased significantly, and the Company's infection prevention and control business and precision medicine integrated solutions business achieved a significant growth during the reporting period. 2. During the reporting period, the Company continued to focus on the main businesses, comprehensively strengthened product research and development innovation, actively expanded domestic and international marketing channels, and took the lead for strategic layoutin the industry's cutting-edge products. The Company's key research and development projects continue to advance smoothly, and product registration declaration made great progress. When the pandemic slows down in the future, the Company will continue to promote the advantages of "Fire Eye" laboratory in large-scale population testing in reproductive health, tumor prevention and control, infection prevention and control, and strive to become an important part of the transformation and upgrading of the healthcare system. 3. During the reporting period, the impact of the Company's non-recurring profit and loss on the company's net profit amounted to about 30 million yuan to 45 million yuan, mainly from government subsidies and equity income.

(By Li Menglin)

Disclaimer: This article is for informational purposes only and does Not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.